Background: Ovarian cancer is one of the leading causes of morbidity and mortality. Objectives: The purpose of the present study was to find out clinic-demographic and histopathological variants of ovarian cancer. Methodology: This cross-sectional study was conducted in the Department of Obstetrics and Gynaecology at four largest tertiary care Hospitals in Dhaka city from January 2008 to December 2009. Clinically diagnosed and histopathologically confirmed ovarian cancer patients were included in this study. Result: Histopathological confirmed 28 patients of ovarian cancer were enrolled in this study. The mean age (±SD) was 40.6 (±12.5) years (Range 13 to 63 years). Lower abdominal lump (71.4%) was the most common symptoms. Family history (14.0%) and multiparty (53.0%) were also associated with ovarian cancer. Among 28 malignant tumors cases serious cyst adenocarcinoma (57.1%) was the most common followed by mucinous cyst adenocarcinoma (17.9%), dysgerminoma (7.1%), adenocarcinoma of ovary (7.1%), ovarian choriocarcinoma (3.6%) and endometriod adeno carcinoma (3.6%). High serum CA125 was found in 78.0% cases. Conclusion: Lower abdominal lump, multiparity and positive family history are the common clinical findings of ovarian cancer. Both serous and mucinous cyst adenocarcinoma are the common varient of ovarian cancer found in this study. [J Shaheed Suhrawardy Med Coll, 2013;5(1):3-6] 
Introduction
Ovarian cancer is the leading cause of death among gynecologic malignancies 1 . It is the 5 th most common cancer among women in the UK 2 . It constitutes about 15.0%-20.0% of genital malignancies 2 . Majority of the ovarian tumors are benign having cystic, solid or mixed characteristics 3 . The remaining 20.0% of these tumors are malignant in nature leading to fatal prognosis 3 . Ovarian cancer is associated with poor prognosis 3 in contrast to other malignancies. It remained poor despite the new chemotherapeutic treatment modalities [3] [4] . This poor prognosis has usually been attributed to the fact that at the time of diagnosis about 70.0% of ovarian cancers have already been widespread intraperitoneal metastases 5 and five years survival is only 28.0% 6 . Furthermore, the lifetime risk of development of ovarian cancer is 5.0%-7.0% 2 . Due to the fatal outcome of this disease, early and accurate diagnosis of ovarian tumor is needed.
It gives an increasing challenge to the gynaecological oncologists who are frustrated by the paucity of knowledge www.jshsmc.org cases used oral contraceptive and 16(53.3%) cases have given the history of high parity (Table 3) . Size of tumor was measured in this study. It was observed that 2(7.1%) cases had 1 to 3 cm, 4(14.3%) cases had 3.1 to 5 cm, 17(60.7%) cases had 5.1 to 10 cm and 5(17.9%) cases had more than 10 cm tumor size (Table 4 ).
Table 4: Size of the tumor among study subjects (n=28)
In this study 28 malignant tumors were found of which 16(57.1%) cases were serous cyst adenocarcinoma, 5(17.9%) cases were mucinous cyst adenocarcinoma, 1(3.6%) case ovarian choriocarcinoma, 1(3.6%) case was endometrioid carcinoma, 2(7.1%) cases were dysgerminoma and 2(7.1%) cases were adenocarcinoma of ovary (Table 5 ).
Table 5: Histopathological categories of malignant tumors among the Study Population (n=28)
It was observed that 6(21.4%) patients had normal serum CA-125. Raised serum CA-125 was found in 22(78.6%) cases ( Table 6 ). who were admitted in the Department of Obstetrics and Gynaecology at BSMMU, DMCH, BMCH and ShSMCH at any age were enrolled for the study. After proper counseling and informed consent, their sociodemographic histories were taken. Different biochemical values including serum CA-125 were measured. Then histopathological examinations were done to confirm ovarian cancer. Computer based statistical analysis were carried out with appropriate techniques and systems. All data were recorded systematically in preformed data collection form (questionnaire) and quantitative data were expressed as mean and standard deviation and qualitative data were expressed as frequency distribution and percentage. Statistical analysis was performed by using window based computer software devised with Statistical Packages for Social Sciences (SPSS-19) (SPSS Inc, Chicago, IL, USA). The summarized data was interpreted accordingly and was then presented in the form of tables.
Results
A total number of 28 cases were examined. Majority of the patients were in the age group of 41 to 50 years of age which was 10(35.7%) cases. The mean age was 40.6±12.5 years with ranged from 13 to 63 years ( Table 1) The symptoms among the study subjects were observed and found that majority were presented with abdominal lump which was 20(71.4%). Weight loss was found in 17(60.7%) cases. Heaviness were found in 13(46.4%) cases. However, 11(39.3%) cases complains of pain. Nearly one third (32.1%) of the subjects had others symptoms ( Table 2 ). period of time are at higher risk of developing ovarian cancer 19 . Overall, multiparous women have a 30 to 70.0% lower risk as compared with nulliparous women 20 .
Regarding the size of tumor it was observed that 1 to 3 cm (7.1%), 3.1 to 5 cm (14.3%), 5.1 to 10 cm (60.7%) and more than 10 cm (17.9%) were commonly detected size of the tumor size among the patients. Kawai et al 21 According to histopathology 28 different malignant tumors were found in this study and serous cyst adenocarcinoma was found in 57.1% cases, mucinous cyst adenocarcinoma was found in 17.9%, ovarian choriocarcinoma was in 3.6% cases, endometroid carcinoma was in 3.6% cases, dysgerminoma was in 7.1% cases and adenocarcinoma of ovary was in 7.1% cases. Schneider et al 9 observed that serous cysadenocarcinoma was found most commonly (53.3%); in addition to that endometrioid carcinoma (26.7%), mucinous cystadenocarcinoma (6.7%) and mixed (combined) type (13.3%) were also reported, which is comparable with the current study. Among histological types, the commonest category of the ovarian tumours encountered in this series was epithelial tumour followed by germ cell tumours. Serous tumours were found to be more common than mucinous. Similar results were reported by Prabhakar 23 in which serous tumours were the commonest followed by mucinous tumours.
In this study it was observed that 21.4% had normal serum CA-125. Raised serum CA-125 was found 78.6% sujects. Kudoh et al 24 observed that 77.6% malignant ovarian tumor showed raised serum CA-125 which is compatible to this study subjects. The preoperative use of CA-125 tumour markers alone has failed particularly in the early detection of malignancy because of false positive results can be expected along with false negative results 25 .
Conclusion
Most common clinical presentation of ovarian cancer is lower abdominal lump, weight loss, with feeling of heaviness. Women with multiparity and positive family history were most commonly encountered with ovarian cancer. Both serous and mucinous cyst adenocarcinoma are the common variant of ovarian cancer found in this study. Detailed history, thorough clinical examination and serum CA125 measurement may help in early detection and timely intervention of ovarian cancer can prevent adverse prognosis to some extent.
Discussion
This cross sectional study was carried out with an aim to evaluate the clinicopathological findings and sociodemographic variables in ovarian cancer. A total of 28 subjects of histopathological proved ovarian tumour age ranging from 13 to 63 years were included in the study who were admitted in the Department of Obstetrics and Gynaecology at BSMMU, DMCH, ShSMCH and BMCH in Dhaka city.
In this study it was found that the mean age was 40.6±12.5 years with ranged from 13 to 63 years which is similar age rage (18-80 years) published by Strigini et al 8 . Maximum number was found in the age group of 41-50 years. Schneider et al 9 have shown in their series that the mean age of the subjects having ovarian cancer was 52.6 years with age range from 33 to 71 years and benign ovarian tumor were 48.0 years of age with range from 16 to 76 years, which is higher with the present study. This may be to low life expectancy among the study population of this study.
This study reveals that the presentation of the ovarian tumor is varied. Some of the ovarian tumours may be incidentally diagnosed on ultrasonography whereas others may present with acute abdominal pain. Regarding the symptoms at presentation of the study subjects it was observed that lump (71.4%) was more common. Weight loss (60.7%), heaviness (46.4%), others symptom (32.1%) and pain (39.3%) were also frequently recorded symptoms. These results differ with a study carried out at Sir Ganga Ram and Myo Hospital Lahore 10 where abdominal pain was the commonest presenting complaint (59.0%) followed by abdominal mass or distension (37.0%). Incessant ovulation is an important determinant of ovarian cancer and factors that suppress ovulation, such as pregnancy, use of oral contraceptive pills (OCP), and lactation play the role in reducing the risk of ovarian cancer 11 . Use of OCP in a life time has been shown to decrease ovarian cancer risk by 40.0% to 50.0% compared with never use 12 . The reduction in risk appears greatest following more than 10 years of use and demonstrated a clear .protective effect of oral contraceptives for ovarian carcinoma [13] [14] [15] . Among the patients it was observed that oral contraceptive received 35.7% patients.
In this study family history of ovarian cancer was found in 14.3% cases. Epidemiologic studies have indicated that after controlling for age, the strongest risk factor for ovarian cancer is a family history of ovarian cancer 16 . The incidence of ovarian cancer attributable to genetic factors is estimated to be in the range of 5.0 to 10% 16 . Women with one firstdegree relative with ovarian cancer have a 5.0% lifetime risk and women with two or more first-degree relatives have a 7.0% risk 17 . The risk is greater for the sisters and daughters than for the mother 17 . Women with a family history of three or more cases of ovarian cancer are more likely to develop ovarian cancer at an younger age 18 .
In this present study it was observed that 53.3% used fertility inducing drugs. Use of fertility inducing drugs, family history of ovarian cancer and use of OCP were significantly higher risk of developing ovarian cancer 19 . Infertile women who received fertility drugs for extended
